Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

dc.contributor.authorChougule, Anil
dc.contributor.authorSharma, Rashmi
dc.contributor.authorTrivedi, V.
dc.contributor.authorThavamani, Abhishek
dc.contributor.authorNoronha, Vanita
dc.contributor.authorJoshi, Amit
dc.contributor.authorDesai, Saral
dc.contributor.authorChandrani, P.
dc.contributor.authorSundaram, P.
dc.contributor.authorUtture, S.
dc.contributor.authorJambhekar, N.
dc.contributor.authorGupta, Sanjeev
dc.contributor.authorAich, J.
dc.contributor.authorPrabhash, Kumar
dc.contributor.authorDutt, Amit
dc.date.accessioned2019-02-12T14:27:18Z
dc.date.available2019-02-12T14:27:18Z
dc.date.issued2014
dc.date.oa2019-09-16
dc.date.pasync2020-09-11T00:30:18Z
dc.date.updated2020-09-11T00:30:18Z
dc.description.correctorLB
dc.identifier.citationBritish Journal Of Cancer. -111 : 11 (2014), p. 2203-2204. -Br. J. Cancer. - 0007-0920
dc.identifier.doihttp://dx.doi.org/10.1038/bjc.2014.401
dc.identifier.issn0007-0920
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM077095
dc.identifier.urihttp://hdl.handle.net/2437/263763
dc.identifier.urlhttp://www.nature.com/articles/bjc2014401
dc.languageeng
dc.rights.accessopen access article
dc.subject.mabOrvostudományok
dc.subject.mabElméleti orvostudományok
dc.titleCoexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
dc.typefolyóiratcikk
dc.typeszerkesztői levél
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nem elérhető
Név:
FILE_UP_1_bjc2014401.pdf
Méret:
231.39 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat